Last Price
1.40
Today's Change
+0.02 (1.44%)
Day's Change
1.30 - 1.44
Trading Volume
106,586
Market Cap
2 Million
Shares Outstanding
1 Million
Avg Volume
756,873
Avg Price (50 Days)
2.18
Avg Price (200 Days)
4.60
PE Ratio
-0.91
EPS
-1.54
Earnings Announcement
18-Nov-2024
Previous Close
1.38
Open
1.30
Day's Range
1.3 - 1.44
Year Range
1.032 - 18.36
Trading Volume
106,592
1 Day Change
1.45%
5 Day Change
-4.11%
1 Month Change
-14.11%
3 Month Change
-60.78%
6 Month Change
-59.77%
Ytd Change
-88.67%
1 Year Change
-91.36%
3 Year Change
-97.51%
5 Year Change
-97.51%
10 Year Change
-97.51%
Max Change
-97.51%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is based in Washington, District of Columbia.